M&A Deal Summary

Galapagos Acquires Sareum Holdings - Drug Discovery business

On August 26, 2008, Galapagos acquired life science company Sareum Holdings - Drug Discovery business from Sareum Holdings for 695M EUR

Acquisition Highlights
  • This is Galapagos’ 4th transaction in the Life Science sector.
  • This is Galapagos’ 0th largest (disclosed) transaction.
  • This is Galapagos’ 3rd transaction in the United Kingdom.

M&A Deal Summary
Date 2008-08-26
Target Sareum Holdings - Drug Discovery business
Sector Life Science
Buyer(s) Galapagos
Sellers(s) Sareum Holdings
Deal Type Divestiture
Deal Value 695M EUR

Target

Sareum Holdings - Drug Discovery business

United Kingdom

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Galapagos

Mechelen, Belgium

website

Category Company
Founded 1999
Sector Life Science
Employees1,397
Revenue 478M EUR (2020)
DESCRIPTION

Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.

DEAL STATS #
Overall 4 of 9
Sector (Life Science) 4 of 8
Type (Divestiture) 2 of 5
Country (United Kingdom) 3 of 3
Year (2008) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-22 ProSkelia SASU

Paris, France

ProSkelia SASU is a phamaceutical company the company R&D operations and a product portfolio of products focused on musculoskeletal diseases (osteoporosis, cachexia and bone metastasis).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-01 Fidelta

Zagreb, Croatia

Fidelta Ltd. is a drug discovery service company with core scientific competencies in inflammation, fibrosis, and anti-infectives. The scope of services provided by Fidelta is complementary to Selvita’s offerings and will enable Selvita to build a competitive advantage in business areas such as DMPK, in vivo pharmacology, and toxicology, as well as increase its scale of operations within medicinal chemistry and in vitro pharmacology. Fidelta is based in Zagreb, Croatia.

Buy -

Seller(S) 1

SELLER

Sareum Holdings

Cambridge, United Kingdom

website

Category Company
Founded 2003
Sector Life Science
Employees6
DESCRIPTION

Sareum is a drug discovery company. The company produces targeted small molecule therapeutics, focusing on cancer and auto-immune disease. Sareum Holdings was founded in 2003 and is based in Cambridge, the United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United Kingdom) 1 of 1
Year (2008) 1 of 1
Mergr

Product

Company

Legal